Alert: Major Price Advance (3/4/20)-CorMedix Inc (NYSEAMERICAN: CRMD).


On 3/4/20, CorMedix Inc (NYSEAMERICAN: CRMD) stock enjoyed a major increase of 13.0%, closing at $6.00. Moreover, trading volume in this advance was above average at 133% of normal. Relative to the market the stock has been weak over the last nine months but has risen 6.6% during the last week.


Current PriceTarget Research Rating

CRMD’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be an important Value Eraser.

CorMedix is currently unrated.

Rating Review

The stock is currently unrated.

About John Lafferty 101900 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.